Nanomedicines Market 2028 By Product, Application, Type, and Geography | The Insight Partners

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Nanomedicines Market - By Product
1.3.2 Nanomedicines Market - By Application
1.3.3 Nanomedicines Market - By Type
1.3.4 Nanomedicines Market - By Region
1.3.4.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. NANOMEDICINES MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. NANOMEDICINES MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS, RESTRAINTS & EXPECTED INFLUENCE OF COVID-19 PANDEMIC
6. NANOMEDICINES MARKET - GLOBAL MARKET ANALYSIS
6.1. NANOMEDICINES - GLOBAL MARKET OVERVIEW
6.2. NANOMEDICINES - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE

7. NANOMEDICINES MARKET - REVENUE AND FORECASTS TO 2028 - PRODUCT
7.1. OVERVIEW
7.2. PRODUCT MARKET FORECASTS AND ANALYSIS
7.3. THERAPEUTICS
7.3.1. Overview
7.3.2. Therapeutics Market Forecast and Analysis
7.4. REGENERATIVE MEDICINE
7.4.1. Overview
7.4.2. Regenerative Medicine Market Forecast and Analysis
7.5. IN-VITRO DIAGNOSTICS
7.5.1. Overview
7.5.2. In-Vitro Diagnostics Market Forecast and Analysis
7.6. IN-VIVO DIAGNOSTICS
7.6.1. Overview
7.6.2. In-Vivo Diagnostics Market Forecast and Analysis
7.7. VACCINES
7.7.1. Overview
7.7.2. Vaccines Market Forecast and Analysis
8. NANOMEDICINES MARKET - REVENUE AND FORECASTS TO 2028 - APPLICATION
8.1. OVERVIEW
8.2. APPLICATION MARKET FORECASTS AND ANALYSIS
8.3. CLINICAL ONCOLOGY
8.3.1. Overview
8.3.2. Clinical Oncology Market Forecast and Analysis
8.4. INFECTIOUS DISEASES
8.4.1. Overview
8.4.2. Infectious Diseases Market Forecast and Analysis
8.5. CLINICAL CARDIOLOGY
8.5.1. Overview
8.5.2. Clinical Cardiology Market Forecast and Analysis
8.6. ORTHOPEDICS
8.6.1. Overview
8.6.2. Orthopedics Market Forecast and Analysis
8.7. OTHER APPLICATIONS
8.7.1. Overview
8.7.2. Other Applications Market Forecast and Analysis
9. NANOMEDICINES MARKET - REVENUE AND FORECASTS TO 2028 - TYPE
9.1. OVERVIEW
9.2. TYPE MARKET FORECASTS AND ANALYSIS
9.3. NANOPARTICLES
9.3.1. Overview
9.3.2. Nanoparticles Market Forecast and Analysis
9.3.3. Metal and Metal Oxide Nanoparticles Market
9.3.3.1. Overview
9.3.3.2. Metal and Metal Oxide Nanoparticles Market Forecast and Analysis
9.3.4. Liposomes Market
9.3.4.1. Overview
9.3.4.2. Liposomes Market Forecast and Analysis
9.3.5. Polymers and Polymer Drug Conjugates Market
9.3.5.1. Overview
9.3.5.2. Polymers and Polymer Drug Conjugates Market Forecast and Analysis
9.3.6. Hydrogel Nanoparticles Market
9.3.6.1. Overview
9.3.6.2. Hydrogel Nanoparticles Market Forecast and Analysis
9.3.7. Dendrimers Market
9.3.7.1. Overview
9.3.7.2. Dendrimers Market Forecast and Analysis
9.3.8. Inorganic Nanoparticles Market
9.3.8.1. Overview
9.3.8.2. Inorganic Nanoparticles Market Forecast and Analysis
9.4. NANOSHELLS
9.4.1. Overview
9.4.2. Nanoshells Market Forecast and Analysis
9.5. NANOTUBES
9.5.1. Overview
9.5.2. Nanotubes Market Forecast and Analysis
9.6. NANODEVICES
9.6.1. Overview
9.6.2. Nanodevices Market Forecast and Analysis
10. NANOMEDICINES MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
10.1. NORTH AMERICA
10.1.1 North America Nanomedicines Market Overview
10.1.2 North America Nanomedicines Market Forecasts and Analysis
10.1.3 North America Nanomedicines Market Forecasts and Analysis - By Product
10.1.4 North America Nanomedicines Market Forecasts and Analysis - By Application
10.1.5 North America Nanomedicines Market Forecasts and Analysis - By Type
10.1.6 North America Nanomedicines Market Forecasts and Analysis - By Countries
10.1.6.1 United States Nanomedicines Market
10.1.6.1.1 United States Nanomedicines Market by Product
10.1.6.1.2 United States Nanomedicines Market by Application
10.1.6.1.3 United States Nanomedicines Market by Type
10.1.6.2 Canada Nanomedicines Market
10.1.6.2.1 Canada Nanomedicines Market by Product
10.1.6.2.2 Canada Nanomedicines Market by Application
10.1.6.2.3 Canada Nanomedicines Market by Type
10.1.6.3 Mexico Nanomedicines Market
10.1.6.3.1 Mexico Nanomedicines Market by Product
10.1.6.3.2 Mexico Nanomedicines Market by Application
10.1.6.3.3 Mexico Nanomedicines Market by Type
10.2. EUROPE
10.2.1 Europe Nanomedicines Market Overview
10.2.2 Europe Nanomedicines Market Forecasts and Analysis
10.2.3 Europe Nanomedicines Market Forecasts and Analysis - By Product
10.2.4 Europe Nanomedicines Market Forecasts and Analysis - By Application
10.2.5 Europe Nanomedicines Market Forecasts and Analysis - By Type
10.2.6 Europe Nanomedicines Market Forecasts and Analysis - By Countries
10.2.6.1 Germany Nanomedicines Market
10.2.6.1.1 Germany Nanomedicines Market by Product
10.2.6.1.2 Germany Nanomedicines Market by Application
10.2.6.1.3 Germany Nanomedicines Market by Type
10.2.6.2 France Nanomedicines Market
10.2.6.2.1 France Nanomedicines Market by Product
10.2.6.2.2 France Nanomedicines Market by Application
10.2.6.2.3 France Nanomedicines Market by Type
10.2.6.3 Italy Nanomedicines Market
10.2.6.3.1 Italy Nanomedicines Market by Product
10.2.6.3.2 Italy Nanomedicines Market by Application
10.2.6.3.3 Italy Nanomedicines Market by Type
10.2.6.4 Spain Nanomedicines Market
10.2.6.4.1 Spain Nanomedicines Market by Product
10.2.6.4.2 Spain Nanomedicines Market by Application
10.2.6.4.3 Spain Nanomedicines Market by Type
10.2.6.5 United Kingdom Nanomedicines Market
10.2.6.5.1 United Kingdom Nanomedicines Market by Product
10.2.6.5.2 United Kingdom Nanomedicines Market by Application
10.2.6.5.3 United Kingdom Nanomedicines Market by Type
10.2.6.6 Rest of Europe Nanomedicines Market
10.2.6.6.1 Rest of Europe Nanomedicines Market by Product
10.2.6.6.2 Rest of Europe Nanomedicines Market by Application
10.2.6.6.3 Rest of Europe Nanomedicines Market by Type
10.3. ASIA-PACIFIC
10.3.1 Asia-Pacific Nanomedicines Market Overview
10.3.2 Asia-Pacific Nanomedicines Market Forecasts and Analysis
10.3.3 Asia-Pacific Nanomedicines Market Forecasts and Analysis - By Product
10.3.4 Asia-Pacific Nanomedicines Market Forecasts and Analysis - By Application
10.3.5 Asia-Pacific Nanomedicines Market Forecasts and Analysis - By Type
10.3.6 Asia-Pacific Nanomedicines Market Forecasts and Analysis - By Countries
10.3.6.1 Australia Nanomedicines Market
10.3.6.1.1 Australia Nanomedicines Market by Product
10.3.6.1.2 Australia Nanomedicines Market by Application
10.3.6.1.3 Australia Nanomedicines Market by Type
10.3.6.2 China Nanomedicines Market
10.3.6.2.1 China Nanomedicines Market by Product
10.3.6.2.2 China Nanomedicines Market by Application
10.3.6.2.3 China Nanomedicines Market by Type
10.3.6.3 India Nanomedicines Market
10.3.6.3.1 India Nanomedicines Market by Product
10.3.6.3.2 India Nanomedicines Market by Application
10.3.6.3.3 India Nanomedicines Market by Type
10.3.6.4 Japan Nanomedicines Market
10.3.6.4.1 Japan Nanomedicines Market by Product
10.3.6.4.2 Japan Nanomedicines Market by Application
10.3.6.4.3 Japan Nanomedicines Market by Type
10.3.6.5 South Korea Nanomedicines Market
10.3.6.5.1 South Korea Nanomedicines Market by Product
10.3.6.5.2 South Korea Nanomedicines Market by Application
10.3.6.5.3 South Korea Nanomedicines Market by Type
10.4. MIDDLE EAST AND AFRICA
10.4.1 Middle East and Africa Nanomedicines Market Overview
10.4.2 Middle East and Africa Nanomedicines Market Forecasts and Analysis
10.4.3 Middle East and Africa Nanomedicines Market Forecasts and Analysis - By Product
10.4.4 Middle East and Africa Nanomedicines Market Forecasts and Analysis - By Application
10.4.5 Middle East and Africa Nanomedicines Market Forecasts and Analysis - By Type
10.4.6 Middle East and Africa Nanomedicines Market Forecasts and Analysis - By Countries
10.4.6.1 South Africa Nanomedicines Market
10.4.6.1.1 South Africa Nanomedicines Market by Product
10.4.6.1.2 South Africa Nanomedicines Market by Application
10.4.6.1.3 South Africa Nanomedicines Market by Type
10.4.6.2 Saudi Arabia Nanomedicines Market
10.4.6.2.1 Saudi Arabia Nanomedicines Market by Product
10.4.6.2.2 Saudi Arabia Nanomedicines Market by Application
10.4.6.2.3 Saudi Arabia Nanomedicines Market by Type
10.4.6.3 U.A.E Nanomedicines Market
10.4.6.3.1 U.A.E Nanomedicines Market by Product
10.4.6.3.2 U.A.E Nanomedicines Market by Application
10.4.6.3.3 U.A.E Nanomedicines Market by Type
10.4.6.4 Rest of Middle East and Africa Nanomedicines Market
10.4.6.4.1 Rest of Middle East and Africa Nanomedicines Market by Product
10.4.6.4.2 Rest of Middle East and Africa Nanomedicines Market by Application
10.4.6.4.3 Rest of Middle East and Africa Nanomedicines Market by Type
10.5. SOUTH AND CENTRAL AMERICA
10.5.1 South and Central America Nanomedicines Market Overview
10.5.2 South and Central America Nanomedicines Market Forecasts and Analysis
10.5.3 South and Central America Nanomedicines Market Forecasts and Analysis - By Product
10.5.4 South and Central America Nanomedicines Market Forecasts and Analysis - By Application
10.5.5 South and Central America Nanomedicines Market Forecasts and Analysis - By Type
10.5.6 South and Central America Nanomedicines Market Forecasts and Analysis - By Countries
10.5.6.1 Brazil Nanomedicines Market
10.5.6.1.1 Brazil Nanomedicines Market by Product
10.5.6.1.2 Brazil Nanomedicines Market by Application
10.5.6.1.3 Brazil Nanomedicines Market by Type
10.5.6.2 Argentina Nanomedicines Market
10.5.6.2.1 Argentina Nanomedicines Market by Product
10.5.6.2.2 Argentina Nanomedicines Market by Application
10.5.6.2.3 Argentina Nanomedicines Market by Type
10.5.6.3 Rest of South and Central America Nanomedicines Market
10.5.6.3.1 Rest of South and Central America Nanomedicines Market by Product
10.5.6.3.2 Rest of South and Central America Nanomedicines Market by Application
10.5.6.3.3 Rest of South and Central America Nanomedicines Market by Type
11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. NANOMEDICINES MARKET, KEY COMPANY PROFILES
12.1. ASTRAZENECA
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. CRISTAL THERAPEUTICS
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. ABLYNX (A SUBSISDIARY OF SANOFI COMPANY)
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. 4. BLUEWILLOW BIOLOGICS
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. PFIZER INC.
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. CYTIMMUNE SCIENCES
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. NANOBIOTIX
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. SIRNAOMICS, INC.
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. STARPHARMA HOLDINGS LIMITED
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. TAIWAN LIPOSOME COMPANY, LTD.
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments
13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS